Seaford Pharmaceuticals Hosts Distinguished Delegation from Diagnostic Green
Seaford Pharmaceuticals Hosts Distinguished Delegation from Diagnostic Green
September 13, 2023
Seaford Pharmaceuticals was honored to host a distinguished delegation from Diagnostic Green, a leading provider of trusted high-quality fluorescence products for physicians worldwide. The delegation included Richard Manner (President and Managing Director), Mike Broome (VP Sales & Business Development), and Michael Manner (Marketing Specialist).
Diagnostic Green, with over 30 years of research in ICG fluorescence products, is recognized as an expert in fluorescence imaging. They supply the market with the leading Indocyanine Green (ICG) agent for Injection, USP, which physicians use to visualize fluorescence and guide their procedures.
(from left to right: Narek Adamyan Product Development Manager at Seaford Pharmaceuticals, Randy Beitz Controller at Seaford Pharmaceuticals, Richard Manner, President and Managing Director of Diagnostic Green; Ron Seales, CEO of Seaford Pharmaceuticals, Tamara Seales, President of Seaford Pharmaceuticals, Mike Broome VP Sales & Business Development of Diagnostic Green, Michael Manner Marketing Specialist of Diagnostic Green, Paola Pavez Marketing Manager at Seaford Pharmaceuticals)
At Seaford Pharmaceuticals, we take pride in partnering with Diagnostic Green to ensure the consistent provision of superior quality products to our valued customers. This collaboration is a testament to our commitment to driving healthcare innovation and improving clinical outcomes.
We were delighted to have this opportunity to engage in fruitful discussions with the leadership team from both organizations. Our President, Tamara Seales, and CEO, Ron Seales, along with the Seaford Leadership Team, explored avenues for further collaboration and innovation in the field of healthcare.
This partnership exemplifies our dedication to providing healthcare professionals with cutting-edge tools and solutions, ultimately contributing to improved patient care and reduced healthcare costs.
Stay tuned for more updates on this collaboration as we work together to make fluorescence imaging the global standard in tissue visualization. For more information, please visit our LinkedIn page and stay connected with the latest developments.
